Carisma Therapeutics Inc. Proceeds from Notes Payable
Carisma Therapeutics Inc. reported Proceeds from Notes Payable of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-04-02.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2018-04-02
- Carisma Therapeutics Inc. proceeds from notes payable for the quarter ending 2016-12-31 was $0.00.
- Carisma Therapeutics Inc. proceeds from notes payable for the quarter ending 2016-09-30 was $0.00.
- Carisma Therapeutics Inc. proceeds from notes payable for the quarter ending 2015-12-31 was $0.00, a 100.00% decline year-over-year.
- Carisma Therapeutics Inc. proceeds from notes payable for the quarter ending 2015-09-30 was $0.00.
- Carisma Therapeutics Inc. proceeds from notes payable for fiscal 2017 was $0.00.
- Carisma Therapeutics Inc. proceeds from notes payable for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- Carisma Therapeutics Inc. proceeds from notes payable for fiscal 2015 was $5.00M, a 49.41% decline from fiscal 2014.
- Carisma Therapeutics Inc. proceeds from notes payable for fiscal 2014 was $9.88M, a 229.43% increase from fiscal 2013.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-04-02 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $0.00 derived: sum of 2 quarters · filed 2018-04-02 | $0.00 10-K · filed 2018-04-02 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $0.00 10-Q · filed 2016-11-14 | ||
| 2016-06-30 | $0.00 10-Q · filed 2016-08-12 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $0.00 derived: sum of 2 quarters · filed 2018-04-02 | $5.00M 10-K · filed 2018-04-02 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $5.00M 10-Q · filed 2016-11-14 | ||
| 2015-06-30 | $5.00M 10-Q · filed 2016-08-12 | |||
| 2014-12-31 | $9.88M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-24 | $9.88M derived: sum of 2 quarters · filed 2017-03-24 | $9.88M 10-K · filed 2017-03-24 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $0.00 10-Q · filed 2015-11-04 | ||
| 2014-06-30 | $0.00 10-Q · filed 2015-08-13 | |||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | $0.00 derived: sum of 2 quarters · filed 2016-03-25 | $0.00 derived: sum of 3 quarters · filed 2016-03-25 | $3.00M 10-K · filed 2016-03-25 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $0.00 derived: sum of 2 quarters · filed 2014-11-13 | $3.00M 10-Q · filed 2014-11-13 | |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-13 | $3.00M 10-Q · filed 2014-08-13 | ||
| 2013-03-31 | $3.00M 10-Q · filed 2014-05-15 | |||
| 2012-12-31 | $1.95M 10-K · filed 2015-03-06 |